Cancer Research Cell Death Mechanisms and Cancer Therapy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 1423-1428, April 1, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bögi, K.
Right arrow Articles by Blumberg, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bögi, K.
Right arrow Articles by Blumberg, P. M.

Differential Selectivity of Ligands for the C1a and C1b Phorbol Ester Binding Domains of Protein Kinase C{delta}: Possible Correlation with Tumor-promoting Activity

Krisztina Bögi, Patricia S. Lorenzo, Zoltán Szállási, Péter Ács, Gerhardt S. Wagner and Peter M. Blumberg1

Molecular Mechanisms of Tumor Promotion Section, Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland 20892-4255 [K. B., P. S. L., P. Á., G. S. W., P. M. B.], and Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 [Z. S.]

Protein kinase C (PKC) represents the major, high-affinity receptor for the phorbol esters as well as for a series of structurally diverse natural products. The phorbol esters function by binding to the tandem C1a and C1b domains in PKC, leading to enzyme activation. Although the typical phorbol esters represent the paradigm for tumor promoters in mouse skin, it is now clear that different high affinity ligands for PKC have distinct biological effects. Thus, the daphnane analogue mezerein is a second-stage promoter, the macrolide bryostatin 1 is a partial antagonist, and certain 12-deoxyphorbol 13-monoesters also function as partial antagonists but with a different pattern of activity. The biochemical basis for these differences is an area of active investigation. In this report, we have examined the relative interaction of ligands differing in structure and pattern of biological response with the C1a and C1b domains of PKC{delta}. We mutated either or both of the C1 domains of PKC{delta}, expressed the constructs in NIH 3T3 cells, and monitored the interaction of the ligands by their ability to induce translocation of the mutated PKC{delta} from the cytosol to the particulate fraction. We found that different ligands showed different dependence on the C1a and C1b domains for translocation. Whereas phorbol 12-myristate 13-acetate and the indole alkaloids indolactam and octylindolactam were selectively dependent on the C1b domain, selectivity was not observed for mezerein, for the 12-deoxyphorbol 13-monoesters prostratin or 12-deoxyphorbol 13-phenylacetate, or for the macrocyclic lactone bryostatin 1. Provocatively, the pattern of response corresponds with the activity of the compounds as complete tumor promoters.

1 To whom requests for reprints should be addressed, at Molecular Mechanisms of Tumor Promotion Section, Laboratory of Cellular Carcinogenesis and Tumor Promotion, Building 37-3A01, National Cancer Institute, 37 Convent Drive MSC 4255, Bethesda, MD 20892-4255. Phone: (301) 496-3189; Fax: (301) 496-8709; E-mail: blumberp@dc37a.nci.nih.gov.

Received 10/21/97. Accepted 2/18/98.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Pu, S. H. Garfield, N. Kedei, and P. M. Blumberg
Characterization of the Differential Roles of the Twin C1a and C1b Domains of Protein Kinase C{delta}
J. Biol. Chem., January 9, 2009; 284(2): 1302 - 1312.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Alzamora, L. R. Brown, and B. J. Harvey
Direct Binding and Activation of Protein Kinase C Isoforms by Aldosterone and 17{beta}-Estradiol
Mol. Endocrinol., November 1, 2007; 21(11): 2637 - 2650.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
Amended Final Report on the Safety Assessment of Glyceryl Dilaurate, Glyceryl Diarachidate, Glyceryl Dibehenate, Glyceryl Dierucate, Glyceryl Dihydroxystearate, Glyceryl Diisopalmitate, Glyceryl Diisostearate, Glyceryl Dilinoleate, Glyceryl Dimyristate, Glyceryl Dioleate, Glyceryl Diricinoleate, Glyceryl Dipalmitate, Glyceryl Dipalmitoleate, Glyceryl Distearate, Glyceryl Palmitate Lactate, Glyceryl Stearate Citrate, Glyceryl Stearate Lactate, and Glyceryl Stearate Succinate
International Journal of Toxicology, May 1, 2007; 26(3_suppl): 1 - 30.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
K. L. Cheeseman, T. Ueyama, T. M. Michaud, K. Kashiwagi, D. Wang, L. A. Flax, Y. Shirai, D. J. Loegering, N. Saito, and M. R. Lennartz
Targeting of Protein Kinase C-{epsilon} during Fc{gamma} Receptor-dependent Phagocytosis Requires the {epsilon}C1B Domain and Phospholipase C-{gamma}1
Mol. Biol. Cell, February 1, 2006; 17(2): 799 - 813.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. L. Alkon, H. Epstein, A. Kuzirian, M. C. Bennett, and T. J. Nelson
Protein synthesis required for long-term memory is induced by PKC activation on days before associative learning
PNAS, November 8, 2005; 102(45): 16432 - 16437.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. V. Stahelin, M. A. Digman, M. Medkova, B. Ananthanarayanan, H. R. Melowic, J. D. Rafter, and W. Cho
Diacylglycerol-induced Membrane Targeting and Activation of Protein Kinase C{epsilon}: MECHANISTIC DIFFERENCES BETWEEN PROTEIN KINASES C{delta} AND C{epsilon}
J. Biol. Chem., May 20, 2005; 280(20): 19784 - 19793.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. V. Stahelin, M. A. Digman, M. Medkova, B. Ananthanarayanan, J. D. Rafter, H. R. Melowic, and W. Cho
Mechanism of Diacylglycerol-induced Membrane Targeting and Activation of Protein Kinase C{delta}
J. Biol. Chem., July 9, 2004; 279(28): 29501 - 29512.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Ananthanarayanan, R. V. Stahelin, M. A. Digman, and W. Cho
Activation Mechanisms of Conventional Protein Kinase C Isoforms Are Determined by the Ligand Affinity and Conformational Flexibility of Their C1 Domains
J. Biol. Chem., November 21, 2003; 278(47): 46886 - 46894.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Slater, J. L. Seiz, A. C. Cook, C. J. Buzas, S. A. Malinowski, J. L. Kershner, B. A. Stagliano, and C. D. Stubbs
Regulation of PKCalpha Activity by C1-C2 Domain Interactions
J. Biol. Chem., May 3, 2002; 277(18): 15277 - 15285.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. G. Kazanietz
Novel "Nonkinase" Phorbol Ester Receptors: The C1 Domain Connection
Mol. Pharmacol., April 1, 2002; 61(4): 759 - 767.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. S. Lorenzo, K. Bogi, K. M. Hughes, M. Beheshti, D. Bhattacharyya, S. H. Garfield, G. R. Pettit, and P. M. Blumberg
Differential Roles of the Tandem C1 Domains of Protein Kinase C {{delta}} in the Biphasic Down-Regulation Induced by Bryostatin 1
Cancer Res., December 1, 1999; 59(24): 6137 - 6144.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. RON and M. G. KAZANIETZ
New insights into the regulation of protein kinase C and novel phorbol ester receptors
FASEB J, October 1, 1999; 13(13): 1658 - 1676.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Medkova and W. Cho
Interplay of C1 and C2 Domains of Protein Kinase C-alpha in Its Membrane Binding and Activation
J. Biol. Chem., July 9, 1999; 274(28): 19852 - 19861.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
R. Zeidman, B. Lofgren, S. Pahlman, and C. Larsson
PKC{varepsilon}, Via its Regulatory Domain and Independently of its Catalytic Domain, Induces Neurite-like Processes in Neuroblastoma Cells
J. Cell Biol., May 17, 1999; 145(4): 713 - 726.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Cho
Membrane Targeting by C1 and C2 Domains
J. Biol. Chem., August 24, 2001; 276(35): 32407 - 32410.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.